Nafithromycin

DB16246InvestigationalSmall molecule

Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).

Chemical structure of Nafithromycin
Formula / weight
C42H62N6O11S · 859.05 g/mol (avg)

Resolves to

Compound
UNII75F74Y2R70CAS1691240-78-4
Structure
InChIKeyRLFCSBSRGRJFRO-BRUOOUDCSA-NSMILES[H][C@]12[C@H](\C(N)=N\O[C@@H](C)C3=NN=C(S3)C3=CC=CC=N3)C(=O)O[C@]1(C)[C@@H](CC)OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@]1([H])O[C@H](C)C[C@@H]([C@H]1O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@@H]2C)OC

What you can answer from here — as of July 08, 2026

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Nafithromycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In